Multi-Target Actives for Hair Enhancement
A 6-active portfolio spanning follicular signaling, collagen modulation, and antioxidant support
For cosmetic formulators developing premium hair enhancement and scalp health products
6
Distinct Actives
≥98%
Purity (HPLC)
1–50 ppm
Peptide Dose Range
pH 3–7
Formulation Stability
Mironova offers six hair enhancement actives that target distinct follicular pathways: K₊ATP channel openers, collagen maturation modulators, ECM remodeling peptides, keratin gene support peptides, and antioxidant ingredients. Our water-soluble formulations eliminate the need for irritating co-solvents, and every active is supported by published literature or supplier efficacy data.
Challenges & Solutions
Your Challenge. Our Answer.
We understand the specific problems you face — and we built solutions for each one.
The Problem
Reliance on a single active (minoxidil) limits formulation differentiation and creates IP constraints for premium positioning
Mironova’s Answer
Mironova offers a multi-target portfolio: Kopyrrol Aqua (PDPO), Kopexil Aqua (DPO), plus cosmetic peptides — each addressing different follicular pathways
6 distinct activesThe Problem
Many hair enhancement actives are poorly water-soluble, requiring organic co-solvents that irritate sensitive scalps
Mironova’s Answer
Both Kopyrrol Aqua and Kopexil Aqua are freely water-soluble OTZ salt forms — clean aqueous formulation without propylene glycol or ethanol
100% water-solubleThe Problem
Regulatory pressure on prostaglandin analogues (EU SCCS opinion, Health Canada hotlist) creates market need for non-PG alternatives
Mironova’s Answer
Our non-prostaglandin actives provide options for regulated markets where PG analogues face restrictions or consumer concerns
The Problem
Ingredient suppliers offer single actives, forcing formulators to manage multiple vendor relationships for a multi-active approach
Mironova’s Answer
Single-source supply for multiple mechanistically distinct actives, simplifying procurement and enabling coordinated formulation support
The Problem
Evolving regulatory frameworks (like MoCRA and EU SCCS) require rigorous safety substantiation and limit the viability of single-mechanism formulations
Mironova’s Answer
Mironova provides a comprehensive, multi-pathway toolkit—from compliant cosmetic peptides and N-oxides to high-efficacy prostaglandin analogs optimized for scalp applications—ensuring long-term R&D continuity
Published Research
Published Evidence
Key findings from peer-reviewed literature relevant to your application.
Collagen Maturation Modulation (DPO)
Targets lysyl hydroxylase — the collagen cross-linking enzyme
Aminexil (DPO) retains strong inhibition of lysyl hydroxylase mRNA expression in vitro, targeting the collagen maturation pathway around hair follicles.
Mahé et al., Skin Pharmacology 1996
K₊ATP Channels in Hair Follicles
Two distinct K₊ATP channel types in follicles
Human hair follicles contain two forms of ATP-sensitive potassium channels, only one of which responds to minoxidil-class openers.
Shorter et al., FASEB Journal 2008
Perifollicular Fibrosis in AGA
Collagenous sheath thickening and inflammatory infiltrates are documented around miniaturizing follicles — a modifiable axis for hair enhancement formulations.
Jaworsky et al., 1992; Li et al., 2025
OTZ as Intracellular Cysteine Prodrug
OTZ is converted to cysteine by 5-oxoprolinase, supporting glutathione biosynthesis. Provides antioxidant support in the formulation’s delivery system.
Williamson & Meister, PNAS 1981
Market Context
A Multi-Pathway Approach to Evolving Regulatory Landscapes
As regulatory scrutiny increases—such as MoCRA's safety substantiation requirements and EU SCCS focus on periocular exposure—the market demands adaptable formulation strategies. Brands can combine non-PG alternatives (N-oxides and cosmetic peptides) for multi-target mechanisms, or pivot high-efficacy prostaglandin analogs to scalp applications, taking advantage of a safer-by-design exposure geometry.
- EU SCCS opinion (Feb 2026) flagged periocular exposure concerns for PG analogs in cosmetics
- MoCRA safety substantiation deadlines are driving brands to diversify active ingredient sourcing
- Premium scalp-care segment growing at 2× the rate of mass-market hair care
EU SCCS/1680/25 (Feb 2026); MoCRA (2022); Mironova regulatory analysis
6
Distinct non-PG actives
15+
Prostaglandin analogs available
Product Catalog
Recommended Products
The specific products from our catalog that match your application.
Application Notes
Formulation Guidelines
Why Mironova
Your Advantage with Mironova
Multi-Target Portfolio
Six actives spanning K₊ATP channel opening, collagen maturation modulation, ECM remodeling, keratin gene support, and antioxidant pathways. Supported by published literature and supplier efficacy studies.
Water-Soluble Salt Forms
Kopyrrol Aqua and Kopexil Aqua are freely water-soluble OTZ salt forms — eliminating the need for propylene glycol, ethanol, or other irritating co-solvents.
Regulatory-Aware Positioning
Claims language is structured around cosmetic-safe phrasing. We do not make drug claims. Mechanism descriptions are qualified by evidence level (in vitro, ex vivo, supplier data).
US-Manufactured, Single Source
All six actives available through one US-based supplier. One vendor qualification, one supply relationship, coordinated formulation support.
Comprehensive Active Platform
From highly purified cosmetic peptides and water-soluble N-oxides to a deep catalog of 15+ prostaglandin analogs (≥98% purity), we offer formulation pathways for every regulatory environment.
Request Technical Data
Get product specifications, CoA samples, and pricing for your evaluation.
FAQ
Frequently Asked Questions
Common technical questions about this product line, answered by our scientific team.
Request Ingredient Samples
Receive evaluation samples of our hair enhancement actives — small-molecule and cosmetic peptide options — with technical data sheets and formulation guidance.
Or call us at +1 (973) 244-0393
Related Resources
Technical data, product specifications, and application guidance.